CBLL
NASDAQCeriBell Inc.
Price$18.56+0.24 (+1.31%)
01:45 PM07:45 PM
News · 26 weeks72+67%
2025-12-212026-06-14
Mix3590d
- Insider22(63%)
- SEC Filings7(20%)
- Other4(11%)
- Earnings2(6%)
Latest news
25 items- INSIDERDirector Taylor Joseph Michael sold $101,255 worth of shares (5,500 units at $18.41), decreasing direct ownership by 8% to 61,573 units (SEC Form 4)4 - Ceribell, Inc. (0001861107) (Issuer)
- INSIDERPresident and CEO Chao Xingjuan sold $714,870 worth of shares (39,000 units at $18.33) as part of a pre-agreed trading plan and exercised 25,000 shares at a strike of $4.70, decreasing direct ownership by 2% to 816,317 units (SEC Form 4)4 - Ceribell, Inc. (0001861107) (Issuer)
- PRCeribell Announces New Critical Care Medicine Publication Reinforcing Link Between Seizure Burden Measured by Clarity AI Algorithm and Neurological OutcomesSUNNYVALE, Calif., June 08, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (NASDAQ:CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that a new research paper entitled "Point-of-Care EEG Artificial Intelligence Measure of Seizure Burden Associates with Clinical Outcome at Discharge" was published in Critical Care Medicine (CCM),1 the official, peer-reviewed scientific journal of the Society of Critical Care Medicine (SCCM). The landmark study provides evidence that Ceribell's Clarity® artificial intelligence (AI) algorithm, specifically its measure of seizure burden, is correlate
- INSIDERDirector Tammenoms Bakker Juliet was granted 7,838 shares, increasing direct ownership by 51% to 23,284 units (SEC Form 4)4 - Ceribell, Inc. (0001861107) (Issuer)
- INSIDERDirector Parvizi Josef was granted 7,838 shares, increasing direct ownership by 51% to 23,284 units (SEC Form 4)4 - Ceribell, Inc. (0001861107) (Issuer)
- INSIDERDirector Rogers Erica J. was granted 7,838 shares, increasing direct ownership by 31% to 33,054 units (SEC Form 4)4 - Ceribell, Inc. (0001861107) (Issuer)
- INSIDERDirector Burke William W was granted 7,838 shares, increasing direct ownership by 45% to 25,229 units (SEC Form 4)4 - Ceribell, Inc. (0001861107) (Issuer)
- INSIDERDirector Taylor Joseph Michael was granted 7,838 shares, increasing direct ownership by 13% to 67,073 units (SEC Form 4)4 - Ceribell, Inc. (0001861107) (Issuer)
- INSIDERDirector Robertson Rebecca B was granted 7,838 shares, increasing direct ownership by 42% to 26,587 units (SEC Form 4)4 - Ceribell, Inc. (0001861107) (Issuer)
- SECCeriBell Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - Ceribell, Inc. (0001861107) (Filer)
- INSIDERChief Revenue Officer Manni Joseph S. sold $24,804 worth of shares (1,378 units at $18.00), decreasing direct ownership by 2% to 56,291 units (SEC Form 4) to satisfy withholding tax4 - Ceribell, Inc. (0001861107) (Issuer)
- INSIDERSenior VP, Finance and PAO Foehr David sold $33,972 worth of shares (1,849 units at $18.37) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 37,751 units (SEC Form 4) (tax liability)4 - Ceribell, Inc. (0001861107) (Issuer)
- INSIDERChief Technology Officer Woo Raymond sold $35,388 worth of shares (1,966 units at $18.00), decreasing direct ownership by 0.99% to 195,682 units (SEC Form 4) (for withholding tax)4 - Ceribell, Inc. (0001861107) (Issuer)
- INSIDERChief Financial Officer Blumberg Scott sold $24,966 worth of shares (1,387 units at $18.00), decreasing direct ownership by 0.93% to 147,683 units (SEC Form 4) (tax withholding)4 - Ceribell, Inc. (0001861107) (Issuer)
- INSIDERPresident and CEO Chao Xingjuan sold $108,540 worth of shares (6,030 units at $18.00), decreasing direct ownership by 0.72% to 830,317 units (SEC Form 4) to satisfy withholding obligation4 - Ceribell, Inc. (0001861107) (Issuer)
- PRCeribell to Participate in the William Blair 46th Annual Growth Stock ConferenceSUNNYVALE, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (NASDAQ:CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that Jane Chao, Ph.D., CEO and Co-founder, will present at the upcoming William Blair 46th Annual Growth Stock Conference in Chicago. The presentation will take place on Wednesday, June 3, 2026, at 9:20 a.m. Pacific Daylight Time / 11:20 a.m. Central Daylight Time. Event: William Blair 46th Annual Growth Stock Conference Date: Wednesday, June 3, 2026Time: 9:20 a.m. PDT / 11:20 a.m. CDT A live and archived webcast of the presentation will be availabl
- SECSEC Form 10-Q filed by CeriBell Inc.10-Q - Ceribell, Inc. (0001861107) (Filer)
- SECCeriBell Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Ceribell, Inc. (0001861107) (Filer)
- PRCeribell Reports First Quarter 2026 Financial ResultsSUNNYVALE, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (NASDAQ:CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today reported financial results for the first quarter ended March 31, 2026. First Quarter 2026 & Recent Highlights Reported total revenue of $26.5 million in the first quarter of 2026, a 29% increase compared to the same period in 2025Ended the quarter with 680 total active accountsAchieved gross margin of 87%Initiated commercial launch of neonate and pediatric products following successful pilotReceived supportive CMS proposed rule for NTAP reimbursement for del
- SECSEC Form 144 filed by CeriBell Inc.144 - Ceribell, Inc. (0001861107) (Subject)
- INSIDERPresident and CEO Chao Xingjuan sold $783,973 worth of shares (39,000 units at $20.10) as part of a pre-agreed trading plan and exercised 25,000 shares at a strike of $4.70, decreasing direct ownership by 2% to 836,347 units (SEC Form 4)4 - Ceribell, Inc. (0001861107) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by CeriBell Inc.SCHEDULE 13G/A - Ceribell, Inc. (0001861107) (Subject)
- INSIDERChief Technology Officer Woo Raymond exercised 11,104 shares at a strike of $4.37 and sold $226,928 worth of shares (11,104 units at $20.44) as part of a pre-agreed trading plan (SEC Form 4)4 - Ceribell, Inc. (0001861107) (Issuer)
- PRCeribell to Participate in the Bank of America Securities 2026 Health Care ConferenceSUNNYVALE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (NASDAQ:CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that Jane Chao, Ph.D., CEO and Co-founder, and Scott Blumberg, CFO, will participate in a fireside chat at the upcoming Bank of America Securities 2026 Health Care Conference. The fireside chat will take place on Wednesday, May 13, 2026, at 3:40 p.m. Pacific Standard Time / 6:40 p.m. Eastern Standard Time. Event: Bank of America Securities 2026 Health Care ConferenceDate: Wednesday, May 13, 2026Time: 3:40 p.m. PST / 6:40 p.m. EST A live and archi
- PRCeribell to Report First Quarter 2026 Financial Results on May 11, 2026SUNNYVALE, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (NASDAQ:CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that it will release financial results for the first quarter of 2026 after the close of trading on Monday, May 11, 2026. Company management will host a conference call to discuss financial results beginning at 1:30 p.m. PT / 4:30 p.m. ET on May 11, 2026. Investors interested in listening to the conference call may do so by dialing (800) 715-9871 for domestic callers or (646) 307-1963 for international callers and providing access code 1880547. A li
CBLL FAQ
6 questionsWhere does CBLL stock trade?
CeriBell Inc. (CBLL) is listed on NASDAQ.What sector and industry is CBLL in?
CeriBell Inc. operates in the Health Care sector, Biotechnology: Electromedical & Electrotherapeutic Apparatus industry.When did CeriBell Inc. go public?
CeriBell Inc. (CBLL) completed its IPO in 2024.What are analysts saying about CBLL?
CeriBell Inc. has had 8 recent analyst actions on file. The most recent action was from Raymond James: Strong Buy with a $1900.00 price target on 2025-10-21. Recent price targets range from $1900.00 to $3200.00.What companies are similar to CBLL?
Notable peers in the same industry include MDT (Medtronic plc.), MASI (Masimo Corporation), SEAS (SeaWorld Entertainment Inc.), LIVN (LivaNova PLC), ITGR (Integer Holdings Corporation). Compare CBLL side-by-side with any of them on Quantisnow.How can I track CBLL on Quantisnow?
Quantisnow aggregates CeriBell Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CBLL to receive live email and push alerts on every new disclosure.